Biopharma R&D teams everywhere face the same dilemma in the development of biologics and vaccines: Increase productivity to meet strict budgets and deadlines, while maintaining or improving data accuracy.
One of the major challenges in batch mammalian cell clarification is cost-effective improvement in filtration in the face of high cell densities.
The production of mAb and recombinant proteins has undergone significant progress in recent decades. Higher titers and increasing cell densities present challenges to upstream and downstream groups alike.
This paper delves deeper into aseptic sampling devices to explain how they offer superior performance in the effort to control contamination.
- Clinical trial sponsors and clinical supply vendors must fully consider all attributes of their supply chains to ensure continuity of supply post-Brexit. This whitepaper outlines many questions that sponsors and vendors alike should ask
This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.
How outsourcing and technologies such as in-line conditioning (IC) and in-line dilution (ILD) can help prevent resource constraints, save time, and reduce manufacturing footprint and overall cost in buffer preparation.
A guide for today’s biopharma executives seeking to navigate through the important considerations necessary to successfully build their own cGMP biomanufacturing facility.
Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.
Discover how through automation, it is possible to achieve data acquisition, process monitoring and control, and batch record generation, allowing more complex unit operations to be run in cGMP environments.
|
|
|
|
|
|
|
|
|